Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-035828
Filing Date
2012-07-02
Accepted
2012-07-02 09:54:23
Documents
1
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3703
  Complete submission text file 0001209191-12-035828.txt   5132
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Issuer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CURAGEN CORP 555 LONG WHARF DR. 11TH FL. NEW HAVEN CT 06511
Business Address
WURZER DAVID M (Reporting) CIK: 0001207118 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31533 | Film No.: 12938698